Worldwide disparities in cardiovascular disease: Challenges and solutions

- Cardiovascular disease is the leading cause of death worldwide.
- Collaborative innovations have led to improvement in cardiovascular outcomes.
- Innovative benefits are not equitable amongst ethnic groups.
- Disparities in cardiovascular medicine are a global problem.
- We highlight phenotypes of disparities around the world, and offer solutions.

The 20th century saw cardiovascular disease ascend as the leading cause of death in the world. In response to the new challenge that heart disease imposed, the cardiovascular community responded with ground breaking innovations in the form of evidence based medications that have improved survival, imaging modalities that allow for precise diagnosis and guide treatment; revascularization strategies that have not only reduced morbidity, but also improved survival following an acute myocardial infarction. However the benefits have not been distributed equitably and as a result disparities have arisen in cardiovascular care. There is tremendous data from the United States demonstrating the many phenotypical forms of disparities. This paper takes a global view of disparities and highlights that disparate care is not limited to the United States and it is another challenge that the medical community should rise and face head on.